Table 4.
The relationship between ALB, ALT, AST, and total bilirubin with 90-day mortality.
| Q1 | Q2 | Q3 | Q4 | P-value | Lower | Normal | Higher | P-value | |
|---|---|---|---|---|---|---|---|---|---|
| ALB | |||||||||
| Survivors | 721 (91.27%) | 554 (96.68%) | 582 (97.49%) | 585 (96.69%) | 0.000 | 572 (90.94%) | 1,870 (96.59%) | 0 (0%) | 0.000 |
| Non-survivors | 69 (8.73%) | 19 (3.32%) | 15 (2.51%) | 20 (3.31%) | 57 (9.06%) | 66 (3.41%) | 0 (0%) | ||
| ALT | |||||||||
| Survivors | 802 (95.25%) | 503 (96.73%) | 552 (95.83%) | 585 (93.30%) | 0.043 | 11 (91.67%) | 2,001 (95.93%) | 430 (92.08%) | 0.0002 |
| Non-survivors | 40 (4.75%) | 17 (3.27%) | 24 (4.17%) | 42 (6.70%) | 1 (8.33%) | 85 (4.07%) | 37 (7.92%) | ||
| AST | |||||||||
| Survivors | 775 (95.68%) | 487 (97.01%) | 602 (96.78%) | 578 (91.60%) | 0.000 | 4 (80.00%) | 1,816 (96.49%) | 622 (91.74%) | 0.000 |
| Non-survivors | 35 (4.32%) | 15 (2.99%) | 20 (3.22%) | 53 (8.40%) | 1 (20.00%) | 66 (3.51%) | 56 (8.26%) | ||
| Total bilirubin | |||||||||
| Survivors | 1,265 (96.34%) | 359 (97.03%) | 217 (93.13%) | 601 (92.60%) | 0.000 | 126 (96.92%) | 2,066 (95.52%) | 250 (91.91%) | 0.021 |
| Non-survivors | 48 (3.66%) | 11 (2.97%) | 16 (6.87%) | 48 (7.40%) | 4 (3.08%) | 97 (4.48%) | 22 (8.09%) |
Q, Quartile of serum ALB, ALT, AST and total bilirubin value.
Lower, lower than clinical normal value.
Normal, clinical normal value.
Higher, higher than clinical normal value.